48 filings
Page 2 of 3
SC TO-C
thne04e gkl5u3uq
25 Feb 21
Information about tender offer
4:01pm
8-K
fp28 wphgln941
25 Feb 21
Tender and Support Agreement
8:19am
8-K
lzrr9
4 Jan 21
Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells
8:30am
8-K
9dqr92m6dvq0br1s3
3 Dec 20
Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
8:15am
8-K
95fjmj
16 Nov 20
Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
4:05pm
10-Q
qxayaapjazsy5
31 Aug 20
Quarterly report
4:18pm
8-K
0nw84t88ak2c0a 8p9p
31 Aug 20
Pandion Reports Second Quarter 2020 Financial Results and Provides
4:05pm
8-K
6ddb2j0n
21 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:35pm
S-8
4cwxu xwodn
17 Jul 20
Registration of securities for employees
9:25am
424B4
dyitxdsac
17 Jul 20
Prospectus supplement with pricing info
9:03am
EFFECT
xmsca9tnt3ukyg2 3c
17 Jul 20
Notice of effectiveness
12:15am
S-1MEF
wi1y06bcqioow0gjxel0
16 Jul 20
Registration of additional securities for an S-1
7:35pm
CERT
gdpjtlh8ze4ksi3e8x
16 Jul 20
Certification of approval for exchange listing
10:16am
SEC STAFF
q1bx5
15 Jul 20
SEC staff action: Order
12:00am
CORRESP
eq80udx7
14 Jul 20
Correspondence with SEC
12:00am
CORRESP
5zvdslpc4kzyexn9w
14 Jul 20
Correspondence with SEC
12:00am
8-A12B
ehy3m 0vy15ub8
13 Jul 20
Registration of securities on exchange
12:00pm
S-1/A
fjnwl1ns9b8v
13 Jul 20
IPO registration (amended)
6:09am